his best bet is

來源: jaydad 於 2013-01-13 20:27:55 [檔案] [博客] [舊帖] [給我悄悄話] 本文已被閱讀：次 (298 bytes)

回答: 急性淋巴細胞性白血病請教由 xinxinren 於 2013-01-13 15:24:34

ponatinib, or Iclusig, formally known as AP24534 in clinical trials, made by a Boston-based company Ariad Pharmaceuticals, Inc.

Iclusig was approved by FDA about a month ago, for treatment of AML and Ph+ ALL that can no longer be controlled by Gleevac and chemotherapies.

您的位置：文學城 » 論壇 » 健康養生 » his best bet is

• should also mention -jaydad- ♂ (434 bytes) () 01/13/2013 postreply 21:14:13

• Thank you so much, that is good news! but -xinxinren- ♀ (90 bytes) () 01/14/2013 postreply 11:50:24

發現Adblock插件